Emerging Therapies: The Latest in Clinical Trials

Friday, June 25 | 5:00 PM – 6:30 PM

Zoom Webinar

Hear more about the ever-changing landscape of bleeding disorders treatment. This panel of providers and researchers will share the basics of clinical trial progression and items of discussion for patients/caregivers to consider with their health care provider when thinking about participation in a trial. The session will also include an overview of the new therapies and the science behind these products currently in clinical trial.


Stacy Crouteau, MD

Dr. Croteau is a pediatric hematologist and clinical researcher at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, where she specializes in bleeding and clotting disorders. She completed her undergraduate and medical education at Brown University and then pursued training in Pediatrics and pediatric Hematology/Oncology at Boston Children’s Hospital and Dana Farber Cancer Institute. Dr. Croteau joined the Boston Hemophilia Center as the associate director in 2014. She enjoys clinical care of pediatric patients and leading research efforts to push the frontier of the quality and innovation in our current standards of medical practice. She currently serves at the primary investigator for several industry-sponsored and investigator initiated clinical trials. Her primary areas of academic interest are early drug development, advancing an approach for rationally designed personalized-prophylaxis regimens in hemophilia, and quality improvement efforts targeting patient transition from pediatric to adult care.


Dateline Live—June 23-25

Free registration. All online.

Register Today
View FULL EVENT Agenda

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.